Sanofi’s $700M Investment in Genetic Diseases

Jan. 30 (Bloomberg) –- Alnylam Pharmaceuticals President & COO Barry Greene and Bloomberg’s Meg Tirrell discuss a new technology that shuts down production of proteins that cause disease with Pimm Fox on Bloomberg Televisions “Taking Stock.” (Source: Bloomberg)

Full Show: Bloomberg Businessweek (03/24)
15:34 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • S&P 500 Winners and Losers for 03/24
  • Full Show: Best of Bloomberg Markets Middle East (03/24)
  • How to Trade the Health Care Select Sector SPDR Fund